Coronary Heart Disease Attributable to Passive Smoking: CHD Policy Model

Overview

Journal Am J Prev Med

Specialty Public Health

Date 2008 Dec 20

PMID 19095162

Citations 8

Authors

James M Lightwood

Pamela G Coxson

Kirsten Bibbins-Domingo

Lawrence W Williams

Lee Goldman

Affiliations

Soon will be listed here.

Abstract

Background: Passive smoking is a major risk factor for coronary heart disease (CHD), and existing estimates are out of date due to recent and substantial changes in the level of exposure.

Objective: To estimate the annual clinical burden and cost of CHD treatment attributable to passive smoking.

Outcome Measures: Annual attributable CHD deaths, myocardial infarctions (MI), total CHD events, and the direct cost of CHD treatment.

Methods: A Monte Carlo simulation estimated the CHD events and costs as a function of the prevalence of CHD risk factors, including passive-smoking prevalence and a low (1.26) and high (1.65) relative risk of CHD due to passive smoking. Estimates were calculated using the CHD Policy Model, calibrated to reproduce key CHD outcomes in the baseline Year 2000 in the U.S.

Results: At 1999-2004 levels, passive smoking caused 21,800 (SE=2400) to 75,100 (SE=8000) CHD deaths and 38,100 (SE=4300) to 128,900 (SE=14,000) MIs annually, with a yearly CHD treatment cost of $1.8 (SE=$0.2) to $6.0 (SE=$0.7) billion. If recent trends in the reduction in the prevalence of passive smoking continue from 2000 to 2008, the burden would be reduced by approximately 25%-30%.

Conclusions: Passive smoking remains a substantial clinical and economic burden in the U.S.

Citing Articles

Environmental Factors in the Rehabilitation Framework: Role of the One Health Approach to Improve the Complex Management of Disability.

Lippi L, de Sire A, Folli A, Turco A, Moalli S, Ammendolia A Int J Environ Res Public Health. 2022; 19(22).

PMID: 36429901 PMC: 9690359. DOI: 10.3390/ijerph192215186.

Smoking, leisure-time exercise and frequency of self-reported common cold among the general population in northeastern China: a cross-sectional study.

Zhou G, Liu H, He M, Yue M, Gong P, Wu F BMC Public Health. 2018; 18(1):294.

PMID: 29486739 PMC: 6389261. DOI: 10.1186/s12889-018-5203-5.

Human cytomegalovirus infection and coronary heart disease: a systematic review.

Du Y, Zhang G, Liu Z Virol J. 2018; 15(1):31.

PMID: 29409508 PMC: 5801777. DOI: 10.1186/s12985-018-0937-3.

The Preventable Risk Integrated ModEl and Its Use to Estimate the Health Impact of Public Health Policy Scenarios.

Scarborough P, Harrington R, Mizdrak A, Zhou L, Doherty A Scientifica (Cairo). 2014; 2014:748750.

PMID: 25328757 PMC: 4195430. DOI: 10.1155/2014/748750.

Comprehensive smoking bans and acute myocardial infarction among Medicare enrollees in 387 US counties: 1999-2008.

Barr C, Diez D, Wang Y, Dominici F, Samet J Am J Epidemiol. 2012; 176(7):642-8.

PMID: 22986145 PMC: 3530376. DOI: 10.1093/aje/kws267.

References

Hodgson T, Cohen A . Medical care expenditures for selected circulatory diseases: opportunities for reducing national health expenditures. Med Care. 1999; 37(10):994-1012. DOI: 10.1097/00005650-199910000-00004. View

Dinno A, Glantz S . Clean indoor air laws immediately reduce heart attacks. Prev Med. 2007; 45(1):9-11. PMC: 2693058. DOI: 10.1016/j.ypmed.2007.03.013. View

Roger V . Epidemiology of myocardial infarction. Med Clin North Am. 2007; 91(4):537-52. PMC: 2537993. DOI: 10.1016/j.mcna.2007.03.007. View

Baigent C, Keech A, Kearney P, Blackwell L, Buck G, Pollicino C . Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005; 366(9493):1267-78. DOI: 10.1016/S0140-6736(05)67394-1. View

Bartecchi C, Alsever R, Nevin-Woods C, Thomas W, Estacio R, Bucher Bartelson B . Reduction in the incidence of acute myocardial infarction associated with a citywide smoking ordinance. Circulation. 2006; 114(14):1490-6. DOI: 10.1161/CIRCULATIONAHA.106.615245. View

Steenland K . Passive smoking and the risk of heart disease. JAMA. 1992; 267(1):94-9. View

van Domburg R, Foley D, Breeman A, van Herwerden L, Serruys P . Coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. Twenty-year clinical outcome. Eur Heart J. 2002; 23(7):543-9. DOI: 10.1053/euhj.2001.2821. View

Ford E, Giles W . Changes in prevalence of nonfatal coronary heart disease in the United States from 1971-1994. Ethn Dis. 2003; 13(1):85-93. View

Brindle P, Emberson J, Lampe F, Walker M, Whincup P, Fahey T . Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ. 2003; 327(7426):1267. PMC: 286248. DOI: 10.1136/bmj.327.7426.1267. View

10.

Vaccarino V, Krumholz H, Yarzebski J, Gore J, Goldberg R . Sex differences in 2-year mortality after hospital discharge for myocardial infarction. Ann Intern Med. 2001; 134(3):173-81. DOI: 10.7326/0003-4819-134-3-200102060-00007. View

11.

DAgostino Sr R, Grundy S, Sullivan L, Wilson P . Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001; 286(2):180-7. DOI: 10.1001/jama.286.2.180. View

12.

. Annual smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 1997-2001. MMWR Morb Mortal Wkly Rep. 2005; 54(25):625-8. View

13.

Lightwood J, Glantz S . Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. Circulation. 1997; 96(4):1089-96. DOI: 10.1161/01.cir.96.4.1089. View

14.

Wilson P, DAgostino R, Levy D, Belanger A, Silbershatz H, Kannel W . Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97(18):1837-47. DOI: 10.1161/01.cir.97.18.1837. View

15.

Parish S, Collins R, Peto R, Youngman L, Barton J, Jayne K . Cigarette smoking, tar yields, and non-fatal myocardial infarction: 14,000 cases and 32,000 controls in the United Kingdom. The International Studies of Infarct Survival (ISIS) Collaborators. BMJ. 1995; 311(7003):471-7. PMC: 2550542. DOI: 10.1136/bmj.311.7003.471. View

16.

. Annual smoking-attributable mortality, years of potential life lost, and economic costs--United States, 1995-1999. MMWR Morb Mortal Wkly Rep. 2002; 51(14):300-3. View

17.

Barnoya J, Glantz S . Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation. 2005; 111(20):2684-98. DOI: 10.1161/CIRCULATIONAHA.104.492215. View

18.

Pirkle J, Bernert J, Caudill S, Sosnoff C, Pechacek T . Trends in the exposure of nonsmokers in the U.S. population to secondhand smoke: 1988-2002. Environ Health Perspect. 2006; 114(6):853-8. PMC: 1480505. DOI: 10.1289/ehp.8850. View

19.

Groeneveld P, Heidenreich P, Garber A . Racial disparity in cardiac procedures and mortality among long-term survivors of cardiac arrest. Circulation. 2003; 108(3):286-91. DOI: 10.1161/01.CIR.0000079164.95019.5A. View

20.

Whincup P, Gilg J, Emberson J, Jarvis M, Feyerabend C, Bryant A . Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurement. BMJ. 2004; 329(7459):200-5. PMC: 487731. DOI: 10.1136/bmj.38146.427188.55. View